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Abstract: Peanut-allergic children might be at risk for reactions to
other legumes. However, it is not always possible to perform multiple
oral food challenges in children. On the basis of patient case history,
in vitro diagnostic tests, and eventually food challenges, we aimed at
developing an algorithm for risk assessment of possible clinical re-
actions to other legumes (soybean, lupine, fresh, and blanched green
pea). Seventy-ﬁve consecutive patients with a positive oral food
challenge to peanut were included in the study. All tests were run as
part of the routine allergy examination. A high proportion of patients
and/or caretakers refused the administered legume oral food chal-
lenges. Obtained diagnoses from histamine release did not correlate
signiﬁcantly to the outcome of the algorithm. Interestingly, threshold
from peanut challenges did not correlate with the risk assessment.
The algorithm presented in this study can be used when advising
peanut-allergic children and their caretakers about what other
legumes to avoid in the diet.
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Due to the severity of peanut-allergic reactions, it isimportant to have speciﬁc and standardized methods for
allergy diagnosis. The double-blind placebo-controlled food
challenge is considered to be the gold standard for food allergy
diagnosis. In children below 3 years, it is accepted to perform
open food challenges.1 The risk associated with an oral food
challenge is outweighed by the beneﬁts provided to patients
that are shown to be less sensitive (or even tolerant) to the food
over time.2,3 Moreover, even the most sensitive patients and/or
their caretakers beneﬁt from a realistic knowledge of their
personal threshold.
Cross-reactivity is observed when preexisting immuno-
globulin E (IgE) antibodies recognize similar epitopes on other
proteins than the protein they were originally sensitized to,4
and several studies on legume cross-reactivity have been
published. Magni et al5 investigated the degree of in vitro
serologic cross-reactivity between peanut allergens and aller-
gens from soybean and lupine seeds by Western blotting and
2D gel electrophoresis. They found that IgE antibodies spe-
ciﬁc for Ara h 3 peanut allergens (an 11S globulin) also
recognized soybean and lupine 11S globulin basic subunits.5
Wensing et al6 reported that patients sensitized to pea ex-
hibited clinically relevant cross-reactivity to peanut where the
protein responsible for the cross-reaction was vicilin (Ara h 1
in peanut).6
A serological cross-reactivity is, however, not synon-
ymous with allergic reactions in the patients. Bernhisel-
Broadbent and Sampson7 and Bernhisel-Broadbent et al8
found in a pediatric population an extensive serologic cross-
reactivity between legume species that was not reﬂected
clinically. On the one hand, it is argued that related allergens
can cause unexpected clinical reactions and, on the other hand,
that these structures can mimic sensitization without clinical
manifestation, which may be a concern in the diagnosis of
patients.9
Although oral food challenges would be ideal to
establish clinical reactivities to other legumes, it is clearly
not feasible to perform 4 to 8 additional food challenges in
peanut-allergic children in the daily routine.
Because peanut-allergic children may be at risk for
reactions to legumes but cannot always be challenged with all
suspected foods, we aimed at developing an algorithm for risk
assessment of possible clinical reactions to other legumes
(soybean, lupine, fresh, and blanched green pea). On the basis
of case history, in vitro diagnostic tests, and, when accepted by
the patient, food challenge, the child was classiﬁed to a high-
or a low-risk group. Furthermore, we compared the threshold
for peanut challenge and tested the ability of histamine release
(HR) as independent diagnostic tools to discriminate between
high- and low-risk patients.
MATERIALS AND METHODS
Patients
The inclusion criterion for the study was a peanut allergy
conﬁrmed by oral food challenge. Seventy-ﬁve consecutive
patients were included in the study: 46 males (61%) and
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29 females (39%). All patients attended the Allergy Centre at
Odense University Hospital, and all tests were run as a part of
the routine allergy examination in the period from November
2000 to November 2005.
All patients but 1 were children or adolescents. The age
of the patients at the time of the positive oral food challenge
was between 7 months and 42 years, the median age being
5 years and 9 months. One patient was not subjected to an oral
food challenge with peanut due to a clear-cut case history of
peanut allergy but was still included in the study as peanut
challenge positive according to the European Academy of
Allergology and Clinical Immunology guidelines.1
Titrated peanut challenges were performed as described
by Taylor et al,10 and the content of peanut in the challenge
meal inducing subjective and/or objective symptoms was de-
termined. Also, the cumulative dose amount of peanut was
recorded. The dose yielding the ﬁrst mild objective symptoms
corresponds to the lowest observed adverse effect level as
reported by Taylor et al.11 Detailed description of the threshold
doses obtained from the peanut challenges will be published
elsewhere.
The investigations applied were routine procedures, and
therefore the local ethics board stated that formal approval was
unnecessary. All testing was only carried out in accordance
with the parents and patients wishes.
Legume-Speciﬁc Risk Assessment
After diagnosis of peanut allergy based on the positive
challenge outcome, it was investigated whether the patients
reacted to other legumes. The patients and/or their caretakers
were asked about observed reactions to soybean, lupine, fresh
green pea, and blanched green pea, which all belong to the
botanical legume family. The answers obtained were grouped
in 3 categories: Bcase history positive or avoids,[ which
included the patients that experienced symptoms upon
ingestion and the patients that avoided the food to prevent
the induction of symptoms from possible cross-reactions;
Bcase history negative and eats regularly,[ which included the
patients that ate the food without experiencing symptoms; and
Bcase history unknown,[ which included patients with no
known case history. The patients with a positive case history or
that avoided the foods were administered a food challenge, but
they all refused due to fear of eliciting symptoms during
challenge. These patients were categorized as having a high
risk of experiencing a reaction after legume consumption. The
patients with an unknown case history were subjected to skin
FIGURE 1. Flow sheet of the algorithm. The numbers in each box correspond to the number of patients in the risk assessment of
possible reactions to soybean/lupine/fresh green pea/blanched green pea, respectively. Eventually, the patients are divided into
high- or low-risk groups. Pea challenges were only performed with fresh green pea. The outcome of the fresh pea challenge was
used to classify the patients as either high or low risk for both fresh and blanched green pea.
WAO Journal & October 2008 Legume Reactions In Peanut-Allergic Children
* 2008 World Allergy Organization 163
prick test (SPT) and/or measurement of speciﬁc IgE (sIgE). If
1 or both results came out positive, the patients were ad-
ministered a food challenge. If the challenge was refused or
the outcome of the challenge was positive, the patients were
grouped in the Bhigh-risk[ group. A negative challenge
outcome grouped the patients in the Blow-risk[ group. The
patients with negative SPTs and sIgE diagnoses were
categorized as Blow-risk[ patients based on the high negative
predictive value of SPT and sIgE diagnoses.7,12 Finally, the
patients that had a negative case history and ate the legume
foods regularly were grouped in the Blow-risk[ group.
The ﬂow sheet in Figure 1 depicts the algorithm by
which the patients were classiﬁed into 2 groups, reﬂecting
either a high risk or a low risk of possible reaction to the
legumes. The outcome of this risk assessment was used in the
guidance of the patients and/or caretakers.
Legumes
Commercially available products of peanut (Arachis
hypogaea), soybean (Glycine max), lupine (Lupinus angusti-
folius), and green pea (Pisum sativum) bought locally were
tested in the study because they are common legumes in the
diet in Denmark. Both fresh and blanched green peas were
tested, where blanched green peas were peas that were brieﬂy
blanched in the manufacturing process before they were frozen
and sold.
Skin Prick Test
Skin prick test was performed with peanut, soybean,
lupine, fresh green pea, and blanched green pea by the prick-
prick method. Also, a negative (saline) and positive control
(histamine; ALK-Abello´, HLrsholm, Denmark) was included.
The criterion for positive result of the test was a wheal with a
diameter of 3 mm or greater, a negative saline control result,
and a positive histamine control result.
Measurement of sIgE
Serum samples were analyzed for IgE speciﬁc for
peanut, soybean, lupine, and green pea using the Phadia
ImmunoCAPTM system based on a ﬂuoroenzyme immunoas-
say (Phadia, Uppsala, Sweden). The cutoff for a positive
diagnosis was 0.35 kUA/L.
Direct HR
Patients were tested in basophil HR by direct stimulation
of patient basophils. Heparinized blood from the patients was
washed with piperazine-N-N’-bis-2-ethanesulfonic acid
(PIPES), pH 7.4 (3.02 g/L PIPES, 19.05 g/L sodium acetate,
0.49 g/L potassium acetate, 1.0 M Tris buffer, 0.088 g/L
sodium chloride, 0.224 g/L magnesium chloride; RefLab ApS,
Copenhagen, Denmark). Supernatant was discarded, and cells
were resuspended in PIPES with interleukin-3 and stimulated
with legumes in 6 different concentrations. The legumes used
were peanut, soybean, lupine, fresh green pea, and blanched
green pea. Legume extracts were performed as follows: 1 g of
legume in 10 mL PIPES was grinded in a Stomacher 80
(Seward Medical Limited, London, UK) for 60 seconds at
high speed with 10 mL. The sample was centrifuged (3000g,
10 minutes, 5-C), and the supernatant was saved as stock
solution. The stock solution was diluted 1:10, and this dilution
was used as the strongest dilution. Five subsequent 3.5-fold
dilutions were prepared. The legume dilutions (25 Kl) were
applied to the glass microﬁber plates together with 25 KL
patient blood sample containing 2 ng/mL interleukin-3.
The histamine was measured spectroﬂuorometrically
according to the glass microﬁber method HR-Test at RefLab
ApS described by Stahl Skov et al.13 An HR of 10 ng/mL or
greater was considered a positive test result. Positive results
were classiﬁed in HR classes 1, 2, and 3, where patients with
positive reactions to 1 or 2 dilutions were classiﬁed as HR
class 1, patients reacting positive to 3 or 4 dilutions were
classiﬁed as HR class 2, and patients reacting positive to 5 or
all 6 dilutions were classiﬁed as HR class 3.14
TABLE 2. Concordances for Pairwise Comparison of the
Diagnostic Tests: SPT, HR, and sIgE
Legume SPT vs HR, % SPT vs IgE, % HR vs IgE, %
Peanut 88 97 90
Soybean 80 70 57
Lupine 67 67 57
Fresh green pea 53 63 52
Blanched green pea 79 63 57
TABLE 3. Mean SPT, Mean HR Class, and Median sIgE for
Patients Grouped Into Positive, Negative, or Unknown Case







Soybean SPT 1 (21) 2.5 (41)
HR 0.1 (19) 0.5 (28)
sIgE 0.3 (21) 0.7 (45)
Lupine SPT V (0) 4 (2) 2.5 (54)
HR V (0) 0 (1) 1.3 (25)
sIgE V (0) V (0) 0.3 (47)
Fresh green pea SPT 2.7 (7) 1.5 (23) 2.8 (30)
HR 1.3 (6) 1.0 (24) 1.2 (25)
sIgE 1 (6) 0.3 (20) 0.4 (25)
Blanched green pea SPT 1.2 (27) 1.9 (32)
HR 0.2 (29) 0.2 (26)
sIgE 0.3 (28) 0.9 (23)
TABLE 1. Frequencies of Positive Diagnostic Tests in
Peanut-Allergic Patients
Legume SPT HR sIgE
Peanut 97% (68/70) 92% (45/49) 97% (69/71)
Soybean 28% (17/60) 19% (9/47) 58% (37/64)
Lupine 45% (23/51) 80% (43/54) 47% (22/47)
Fresh green pea 41% (17/41) 91% (39/43) 48% (23/48)
Blanched green pea 16% (6/38) 5% (2/43)
Values in parentheses are the number of patients with positive outcome of the tests
divided by the number of patients having the tests performed.
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Histamine release was not a part of the allergy
diagnostic workup and was only performed if there was an
indication of a reaction. Therefore, HR data were not included
in the algorithm.
Statistics
Speciﬁc IgE results were compared with case history
outcomes by t test. Obtained HR classes were compared with
the classiﬁcation of patients into high- and low-risk groups by
W2 test. Threshold levels from peanut challenges were
compared with the classiﬁcation of patients into high- and
low-risk groups by t test.
RESULTS
All 75 patients in the study had a clinically conﬁrmed
peanut allergy based on the European Academy of Allergol-
ogy and Clinical Immunology guidelines.1
Table 1 shows frequencies of positive results obtained
with the 3 different diagnostic tests: SPT, HR, and sIgE. The
FIGURE 2. Comparison between high- and low-risk classiﬁcation and HR class for the soybean, lupine, fresh green pea, and
blanched green pea. Black lines represent the median.
FIGURE 3. Box plot depicting the comparison between high- and low-risk classiﬁcation and threshold doses of the peanut
challenge.
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diagnostic tests SPTand HR produced most positive results for
lupine and fresh green pea, followed by soybean and blanched
green pea. The measurements of sIgE gave most positive
results for soybean followed by pea and lupine.
Pairwise comparisons between the 3 diagnostic tests
were performed (Table 2). In 4 of 5, the concordance was
lowest between HR and sIgE.
The ﬂow sheet depicting the developed algorithm for
risk assessment of the patient’s potential reaction to other
legumes is depicted in Figure 1. A high fraction of the patients
had an unknown case history to the legumes (71% for soybean,
96% for lupine, 45% for fresh green pea, and 56% for
blanched green pea). The patients in this group with either a
positive SPT and/or sIgE were administered an oral food
challenge.
A high proportion of patients and/or caretakers refused
the oral food challenge (44% for soybean, 75% for lupine,
66% for fresh green pea, and 65% for blanched green pea).
The positive case history or the positive result of the in vitro
diagnosis may explain these high proportions of patients
refusing challenge.
The fraction of the patients designated to the high-risk
group was 25% for soybean, 53% for lupine, 33% for fresh
green pea, and 29% for blanched green pea.
Table 3 depicts the means of SPT and HR, as well as the
median of sIgE measurements, where the patients were
grouped in positive, negative, and unknown case history.
Signiﬁcant differences (P G 0.05) were observed for sIgE
results for fresh green pea between patients with positive and
negative case history (P = 0.007) and for sIgE results for
blanched green pea between patients with negative and
unknown case history. Generally, the mean for SPT and HR
and the median for sIgE were lowest for patients with negative
case history (P = 0.047).
The outcome of the HR diagnostic test was compared
with the classiﬁcation of patients into high- and low-risk
groups. Figure 2 shows the distribution of the HR classes be-
tween high- and low-risk groups. There is a tendency for
soybean and lupine that HR classes are higher for patients in
the high-risk groups; however, this was not signiﬁcant. Figure 2
indicates that the HR test was too sensitive for fresh green pea.
Peanut HR classes were also compared with the high-
and low-risk classiﬁcation. No difference was observed, partly
explainable by the fact that 39 of 49 patients were HR class 3
on which the HR analyses was performed (data not shown).
The outcome of the risk assessment was also compared
with the threshold of the peanut challenge (Fig. 3). Interest-
ingly, no correlation was observed for any of the legumes.
DISCUSSIONS
There is increasing evidence that patients with peanut
allergy frequently cross-react serologically with other
legumes, but only a subpopulation of these patients experience
clinical reactions to the legumes. The frequency of clinical
cross-reactivity to legumes in peanut-allergic patients is not
clear because these patients either avoid legumes, are not
aware of the existence of legumes in different foods, or refuse
to be orally challenged with these foods.
The aim of the present study was to examine frequency
of serological cross-reactivity to soybean, lupine, fresh, and
blanched green pea and to compare these results with
challenge and case history outcome. This approach was the
basis for the development of an algorithm by which it is
possible to divide the peanut-allergic patients into a high- and
low-risk group reﬂecting the precautions the patients must take
in the diet.
Histamine release as an independent diagnostic test
could not predict the outcome of the algorithm giving the high-
and low-risk classiﬁcation. The comparison of SPT and sIgE
with the algorithm outcome was not performed because SPT
and sIgE were a part of the algorithm.
We expected the most sensitive peanut-allergic patients
to also experience more clinically relevant cross-reactivity to
the other legumes. Interestingly, the high- and low-risk
classiﬁcation was not dependent of the threshold dose of the
peanut challenge.
Twenty-eight percent of the patients had a positive SPT
to soybean, whereas for only 2 of 44 patients (5%; the 22 with
a negative case history were included as challenge negative),
the allergy was conﬁrmed clinically by challenge. These
numbers are in agreement with Bock and Atkins15 who
investigated 32 clinically conﬁrmed peanut-allergic patients.
They found that 10 patients (31%) had a positive soybean SPT,
whereas only 1 patient (3%) had a clinical reaction after
ingestion of soybean.
Case history reports from the patients and/or caretakers
reﬂect that lupine is a new and unknown source of allergens
important for peanut-allergic individuals. Only 3 patients were
aware of having ingested or reacted to lupine, and of these,
1 had a positive case history. These data indicate that the
awareness of lupine as a food allergen in Denmark is still
sparse. A search for the combination of Bpeanut,[ Ballergy,[
and Blupine[ at PubMed gave only 13 hits, where the ﬁrst is
published in 1994 and is a report on reactions to lupine added
to pasta.16 It is important to emphasize that the risk of
coallergy to lupine for peanut-sensitized subjects might be
higher than for other legumes, but more knowledge needs to
be gained on this matter. Moneret-Vautrin et al17 investigated
24 peanut-allergic patients, and they found that 44% had a
positive SPT to lupine, which is in agreement with our data
where 45% had a positive lupine SPT. These authors also
found that the risk of crossed peanut-lupine allergy was higher
compared with cross-allergy to other legumes. This risk
combined with the fact that lupine is added frequently to foods
as an excellent protein source is making lupine an allergen of
interest for future research.
Positive SPT frequencies were 41% and 16% for fresh
and blanched green pea, respectively. Bernhisel-Broadbent
and Sampson7 investigated 69 patients with 1 or more positive
SPTs to legumes in 1989 and found that 26% of pea SPTs were
positive (it is not stated whether fresh or blanched green pea
was used).
Eleven patients reported symptoms upon ingestion of
fresh green pea, whereas no patients observed symptoms after
ingestion of blanched green pea. The degradation of pea
allergens by heat treatment can explain this. Peanut and lupine
has been reported to be stable to heat treatment.18Y20 This
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stability can explain that clinically relevant reactions are seen
to peanut and lupine.
Many patients were not challenged in the study but were
still assigned to the high-risk group. Although no scientiﬁc
reason is given for this classiﬁcation, it is advisable from a
practical point of view to consider these patients as high-risk
patients until the opposite has been proven.
This study is the ﬁrst to standardize the process of
diagnosing peanut-allergic children with regard to possible
cross-reactions to other foods. By using the algorithm pre-
sented in this study, it is possible to advise peanut-allergic
children and caretakers on which other legumes to avoid in
their diet.
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